Research ArticleArticle
Metabolism and Pharmacokinetics of Novel Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor Apatinib in Humans
Juefang Ding, Xiaoyan Chen, Zhiwei Gao, Xiaojian Dai, Liang Li, Cen Xie, Haoyuan Jiang, Lijia Zhang and Dafang Zhong
Drug Metabolism and Disposition June 2013, 41 (6) 1195-1210; DOI: https://doi.org/10.1124/dmd.112.050310
Juefang Ding
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Xiaoyan Chen
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Zhiwei Gao
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Xiaojian Dai
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Liang Li
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Cen Xie
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Haoyuan Jiang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Lijia Zhang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Dafang Zhong
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (J.D., X.C., Z.G., X.D., L.L., C.X., D.Z.); and Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, China (H.J., L.Z.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Metabolism and Pharmacokinetics of Apatinib in Humans
Juefang Ding, Xiaoyan Chen, Zhiwei Gao, Xiaojian Dai, Liang Li, Cen Xie, Haoyuan Jiang, Lijia Zhang and Dafang Zhong
Drug Metabolism and Disposition June 1, 2013, 41 (6) 1195-1210; DOI: https://doi.org/10.1124/dmd.112.050310
Research ArticleArticle
Metabolism and Pharmacokinetics of Apatinib in Humans
Juefang Ding, Xiaoyan Chen, Zhiwei Gao, Xiaojian Dai, Liang Li, Cen Xie, Haoyuan Jiang, Lijia Zhang and Dafang Zhong
Drug Metabolism and Disposition June 1, 2013, 41 (6) 1195-1210; DOI: https://doi.org/10.1124/dmd.112.050310
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement